SA
GLAXF logo
GSK plc(GLAXF)
Last print unknown agoAbout this dataData status
$23.40▼-1.05 (-4.29%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 29.7 · elevated volatility

Overview →

GSK plc (GLAXF)

R&D Expenses

£7.57B

TTM · Period ending: · GBP

GLAXF logo

GLAXF R&D Expenses

Latest reported£7.57B GBP
GLAXF R&D Expenses · GBP (£113.00M → £7.57B)
High-resolution chart · PNG

What is r&d expenses?

Research and development spending.

GLAXF r&d expenses history

Annual fiscal periods · GBP. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc R&D Expenses — Annual fiscal periods (GBP)
Period endingR&D Expenses (GBP)
7,506,783,000
6,401,000,000
6,223,000,000
5,488,000,000
5,278,000,000
4,793,000,000
4,568,000,000
3,893,000,000
4,476,000,000
3,628,000,000
3,560,000,000
3,450,000,000
3,923,000,000
3,528,891,000
3,693,520,000
4,354,242,000
3,990,303,000
2,959,117,000
3,257,852,000
3,521,161,000
3,136,000,000
2,904,000,000
2,791,000,000
2,900,000,000
2,560,904,000
2,526,000,000
1,269,000,000
1,163,000,000
1,148,000,000
1,161,000,000
1,540,000,000
858,000,000
739,000,000
595,000,000
475,000,000
420,000,000
323,000,000
230,000,000
149,000,000
113,000,000

Frequently asked questions: GLAXF r&d expenses

What is GSK plc (GLAXF)'s current r&d expenses?

GSK plc (GLAXF)'s latest reported r&d expenses (TTM) is £7.57B as of Sep 30, 2026. Research and development spending.

How much historical r&d expenses data is available for GLAXF?

Stock Alarm Pro provides 40 dated annual fiscal periods observations for GSK plc (GLAXF)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare GLAXF's r&d expenses to peers or set an alert?

You can open GLAXF's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GLAXF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.